Background: Myf5 is one member of the basic helix-loop-helix family of transcription factors, and it functions as a myogenic factor that is important for the specification and differentiation of muscle cells. The expression of myf5 is somite-and stage-dependent during embryogenesis through a delicate regulation. However, this complex regulatory mechanism of myf5 is not clearly understood.
Background
Members of the basic helix-loop-helix (bHLH) family of transcription factors, such as Myf5, MyoD, Myogenin, and MRF4, are crucially important in the specification and differentiation of skeletal muscle progenitors [1] . These myogenic regulatory factors (MRFs) activate muscle-specific transcription by binding to an E-box in the promoter of numerous muscle-specific genes [2, 3] . MRF genes are expressed in zebrafish somites in a characteristic temporal sequence, with myf5 at 7.5 hours postfertilization (hpf) [4] , myod at 8 hpf [5] , and myogenin at 10.5 hpf [5] . The same temporal sequence occurs in mice [1] . These observations indicate that myf5 is the first MRF expressed during vertebrate myogenesis.
Mechanisms that lead to Myf5 activation at multiple sites in mouse embryos have been described [6, 7] . Yeast artificial chromosomes (YAC) [6] and bacterial artificial chromosomes (BAC) [7] have been used to map the promoter of mouse myf5, suggesting that several different cis-regulatory elements are required to activate myf5 expression in different cells at different developmental times. An enhancer at -6.6 kb is required for myf5 expression in the epaxial domain [8] . A 270-bp core enhancer at -57 kb directs myf5 expression in limbs and maintains myf5 expression in somites [9] . In Xenopus, two negative regulatory elements have been identified: an interferon regulatory factor-like DNA binding element that down-regulates Xmyf5 expression in differentiating myocytes [10] , and a distal TCF-3 binding site by which Wnt/β-catenin signaling restricts Xmyf5 expression to the midline mesoderm [11] . A T-box binding site mediates dorsal activation of Xmyf5 transcription and is involved in the regulation of muscle development [12] . Using transient expression of transgenes, we previously identified some cis-elements that regulate zebrafish myf5 [4, 13, 14] . Recently, Lee et al. [15] demonstrated that Foxd3 binds to the -82/-62 regulatory module and regulates zebrafish myf5 expression during early somitogenesis. These observations highlight the complicated and dispersed nature of the upstream elements that control somite-and stage-specific expression of myf5.
To elucidate the nature of this finely tuned control mechanism, we needed a transgenic line that recapitulates the specific endogenous expression pattern of myf5. Such a line requires a transgene that contains a very long upstream region of myf5. We modified the techniques used in mice [16, 17] and present here a highly efficient method for engineering zebrafish BAC. The BAC is an Escherichia coli F factor-based vector that is capable of propagating cloned DNA fragments up to 300 kb long [18] . Previously, Jessen et al. [19] reported a homologous recombination technique for BAC cloning to generate transgenic zebrafish. This technique, however, is rather laborious because it requires a chi-based plasmid with a very large recombination targeting region. With our new method, we efficiently generate transgenic lines containing a 156-kb genomic sequence of myf5 (80-kb upstream and 70-kb downstream segments) replaced with green fluorescent protein (GFP) in the coding region. We find that the 156-kb genomic sequence is long enough to recapitulate the endogenous myf5 transcription pattern during the somitogenesis and pharyngula development stages. To characterize the functions of individual cis-regulatory elements, we also generated several transgenic lines that carry various lengths of the zebrafish myf5 upstream sequence. Comparing the GFP expression patterns of these lines, we identified and characterized the functions of upstream regulatory elements, including a repressive element and tissue-specific enhancers for jaw and fin muscles, bones, eyes, somites, olfactory organs, and the presomitic mesoderm. Whole-mount in situ hybridization reveals that endogenous zebrafish myf5 transcripts are first detectable in the presomitic mesoderm [4] . In contrast, myf5 expression has not been observed by in situ hybridization in the presomitic mesoderm of mouse embryos, although weak signals have been detected by reverse transcriptasepolymerase chain reaction (RT-PCR) [20, 21] . These comparisons illustrate the advantage of our transgenic lines for studying the initiation and regulation of myf5, particularly in the presomitic mesoderm.
Results

Genomic organization of zebrafish myf5 is conserved with mammals
We cloned the myf5 genomic locus using a sequential screening method. We screened 10 primary pools of zebrafish BAC library clones using PCR; one (P1) was positive. We then screened 48 secondary pools derived from P1 and found 5 positive pools. Subsequent screening of the positive pools identified a single myf5-positive BAC clone with a 156-kb insert as indicated by PFGE. We searched sequence databases from the Sanger Institute and identified a contig, ctg9418, which contains the entire sequence of the myf5 BAC clone. BLAST analysis using the myf5 coding region and junction sequences flanking the T7 and SP6 sites showed that the BAC clone spans the sequences of ctg9418 from 1460 to 1304 kb, with the coding sequence starting at 1380. Thus, the myf5 5' and 3' regions contained in this BAC clone extend approximately 80 kb and 70 kb, respectively, beyond the coding sequence.
Radiation hybrid mapping of zebrafish myf5 revealed that myf5 is located on linkage group 4 (LG4), between expressed sequence tags (ESTs) fb62d08 and fb78c03, and at 5.87 CR from EST marker z9667 (data not shown). This syntenic relationship indicates that the region of zebrafish LG4 between EST markers fa05f06 and fk68a09 (includ-ing myf5) is conserved with human chromosome 12q13-12q21.
DNA fragments of myf5:GFP are inherited
We generated several transgenic lines by microinjecting zebrafish embryos with myf5:GFP BAC segment and raising them to adulthood. We identified germ-line transmission by looking for GFP fluorescence in embryos from crossing with wild-type fish. We generated 4 lines with the entire myf5 upstream segment (the 156-kb group: 80k-5, -18, -21, and -23; Fig. 1A ), 4 lines with -9977/-1 (10k-2, -13, -9R, -15R; Fig 
The 156-kb genomic sequence of myf5 drives GFP expression in muscle precursors
In embryos derived from myf5:GFP transgenic lines with the 156-kb genomic sequence (an upstream 80-kb segment and a downstream 70-kb segment; Fig. 1A ), GFP fluorescence first appears very weakly at 7.5 hpf (data not shown), reaches detectable levels in the segmental plate by 10.5 hpf ( Fig. 2A) , and expands to 14 somite pairs in 16 hpf embryos ( Fig. 2B ). At 16 hpf, the GFP signals are strong and mainly restricted to the somites and segmental plates and fluorescence is reduced in the more rostral (older) somites. Prominent GFP signals also appear in the adaxial cells ( Fig. 2B ). The GFP mRNA in embryos derived from myf5:GFP transgenic lines were also detected by using digoxigenin (DIG)-labeling GFP riboprobes. The GFP transcripts were detectable at 7.5 hpf ( Fig. 2F ) and 10.5 hpf ( Fig. 2G ), which matches the spatial and temporal pattern of endogenous myf5 expression as indicated by mRNA in situ hybridization (Figs. 2C-2E) [4] . These results indicate that expression of GFP in the myf5:GFP transgenic line recapitulates endogenous myf5 expression. By 28 hpf, GFP fluorescence is absent from rostral (older) somites (Figs. 3A and 3B). Cross-sections reveal that GFPpositive cells are distributed throughout the myotome (Fig. 3C ). We use the F59 antibody to label slow muscle fibers and find that both slow and fast muscle fibers express GFP in the myf5:GFP transgenic line (Figs. 3D and 3E). In addition, we find no significant differences when comparing the GFP expression patterns of the four independent myf5:GFP lines (80k-5, -18, -21, and -23), indicating that expression of the transgene is unaffected by its chromosomal location.
GFP expression reveals the development of head skeletal muscles
By the end of segmentation stages, pectoral fin (pm) and myotomal (m), dorsal rostral myotomal (drm), muscle precursors express GFP (Figs. 4A and 4B). By 36 hpf, in addition to muscle precursors of pm, m, and drm, two eye muscle precursors, the superior oblique (so) and inferior oblique (io), also express GFP (Figs. 4C-4E) and endogenous myf5 transcripts (Figs. 4F-4H). At 60 hpf, GFP signals are observed in almost all cranial muscle precursors, including the adductor hyomandibulae (ah), adductor mandibulae (am), adductor operculi (ao), constrictor hyoideus ventralis (chv), dilatator operculi (do), inferior oblique (io), lateral rectus (lr), medial rectus (mr), sternohyoideus (sh), superior oblique (so), and transverse ventralis (tv1-5) (Figs. 5A and 5B). Compared with the broad expression of GFP fluorescence, expression in both GFP and endogenous myf5 transcripts is restricted to a tiny spot on each pharyngeal arch at this stage on lateral views (Figs. 5C and 5F, arrows) by using whole-mount in situ hybridization. However, either GFP or myf5 signals were observed at this stage on ventral views (Figs. 5D and 5G). Thus, we conclude that this inconsistency between GFP mRNA and fluorescence should be due to the stability of GFP that persists even though transcription of myf5 has ended. Based on these observations, we propose that most and possibly all cranial muscle precursors transiently express myf5 before 60 hpf, although myod expression is still evident at this stage ( Fig. 5E ).
Proximal element regulates myf5 expression in the presomitic mesoderm
A unique characteristic of myf5 expression, compared with other known MRFs, is its strong and widespread expression in the presomitic mesoderm ( Fig. 2B ). We used the transgenic lines to identify the regulatory sequences required for this aspect of myf5 expression. At 16 hpf, Tg(myf5(80K):GFP) embryos show strong GFP expression in adaxial cells, presomitic mesoderm, and developing somites ( Fig. 6A ). Transgenic lines carrying shorter upstream segments, -9977/-1 Tg(myf5(10K):GFP) ( Fig.  6B) , Table  1) , also show strong GFP signals in the presomitic mesoderm. However, in the transgenic line carrying the -290/-1 segment Tg(myf5(0.3K):GFP), the GFP signal in the presomitic mesoderm is weak (Table 1 ). These results suggest that the minimal enhancer that regulates myf5 expression in the presomitic mesoderm is located within the -290/-1 segment.
Repressive element located at -80/-10 kb blocks GFP expression in notochord driven by module -2937/-2457
We observe no GFP signal in the notochords of embryos derived from line Tg(myf5(80K):GFP). However, Construction of a myf5:GFP bacterial artificial chromosome (BAC) and deletion constructs for germ-line transmission in zebrafish Table 1 ), suggesting that the -2937/-2457 segment contains a notochord enhancer element. To test this hypothesis, we constructed and microinjected three different GFP expression plasmids: pEGFPmTATA contains a TATA-box of CMV fused to EGFP, pEGFPm(2937/2457) contains one copy of segment -2937/-2457, and pEGFPm(2457/2937) contains segment -2937/-2457 in the opposite orientation (Additional file 1). Only 5.1% (6 of 104) of pEGFP-mTATA-injected embryos are GFP-positive, and in no cases is GFP expressed either in notochord or myocytes (Additional file 1). However, 48.4% of pEGFPm(2937/ 2457)-injected embryos and 44.5% of pEGFPm(2457/ 2937)-injected embryos express GFP in both notochord and myocytes (Additional file 1). Thus, the -2937/-2457 segment is a typical, orientation-independent enhancer module for myf5 expression in notochord and myocytes.
Multiple modules regulate myf5 expression in the spinal cord, bones, eyes, and olfactory pits
In embryos derived from Tg(myf5(6K):GFP), GFP fluorescence appears in adductor mandibulae (am) and dorsally caudal to the hindbrain at 48 hpf ( Fig. 8A ). By 72 hpf, GFP fluorescence is stronger and extends farther caudally ( (Fig. 8H ). We find no significant differences when comparing the GFP expression patterns of the four independent myf5:GFP lines (6k-9R, -10R, -11R, -16R), indicating that expression of the transgene is unaffected by its chromosomal location. In the head of embryos derived from Tg(myf5(3K):GFP), GFP is expressed primarily in the eyes (Fig. 8I ) and olfactory placode ( Fig. 8J ), suggesting that eye and olfactory enhancers are located within the -2937/-291 segment. Again, we believe that expression of the transgene is unaffected by its chromosomal location, because no significant differences were observed when comparing the GFP expression patterns of the three independent myf5:GFP lines (3k-18R, -92R, -104R).
Discussion
Stable transgenic lines provide greater sensitivity for studies of gene regulation and confirm transient transgenesis studies
To understand the complex spatial and temporal regulation of myf5 expression, we analyzed the function of the zebrafish myf5 promoter using transgenic constructs. Our previous analysis of embryos injected with various lengths of myf5 promoter driven reporter genes (transient transgenesis) showed that -9977/-1 [22] , -6212/-1 [4] , and -2937/-1 [13] produce GFP-positive signals in the noto-Tg(myf5(80k):GFP) transgenic embryos express green fluorescent protein (GFP) in both slow and fast muscle fibers chord, whereas no fluorescence is observed in the notochord when embryos are injected with -2456/-1 [13] . These observations suggest that the notochord-specific element is located in the -2937/-2457 segment, consistent with the germ-line transmission analysis of our present study (Fig. 9 ).
The regulatory elements for muscle lineage-specific expression, including slow and fast myotomes, are controlled by Hedgehog signaling and myocyte enhancer factor 2 (MEF2) [8, [23] [24] [25] . We propose that the somite-and myotomal-restricted enhancer element is located within the -290/-1 segment ( Fig. 9 ). Thus, it is important to look for the putative myotomal enhancers, such as Hedgehogresponsive elements and MEF2-binding sites within this segment. After sequence analysis, we find that there are one MEF2-binding (-277/-268) and two Gli-binding (-252/-243 and -196/-183) sites located within the -290/-1 segment. In addition, our previous studies showed that the -82/-62 cassette that contains a binding site for the cognate trans-acting factor Foxd3 [15] is able to drive transient expression in somites [14] . On the basis of these Expression of green fluorescent protein (GFP) in Tg(myf5(80K):GFP) transgenics matches the dynamic pattern of endogenous myf5 expression in cranial muscles observations, we propose that -82/-62 motif is a key element for driving somite specificity, and multiple elements within the -290/-1 segment such as MEF2-and Gli-binding sites are responsible for myotomal expression. Together, these results demonstrate that transient analysis is suitable for rapid identification of putative cis-elements, whereas germ-line transmission studies provide great sensitivity and enable confirmation.
Many myf5 regulatory modules are similar between mouse and zebrafish
Few reports have proposed using transgenic animals to study the delicate transcriptional regulation of myf5. Only three species (mice, zebrafish, and Xenopus) have been documented so far. With limited information on the interactions between trans-acting factors and their binding sequences upstream of the myf5 gene, the alternative ways to study transcriptional mechanistic conservation are those making comparisons of sequence similarities and genomic organizations of the myf5 gene among these three known species. As in zebrafish, myf5 expression is regulated by multiple upstream sites in mouse embryos [7, 26] . Multiple enhancers are distributed throughout a 90-kb region of the mouse mrf4/myf5 locus, including a limb enhancer at -58/-48 kb, two head muscle enhancers at -88/-63 and -45/-23 kb, a repressive element at -58/-8.8
Green fluorescent protein (GFP) persists in cranial muscles of Tg(myf5(80k):GFP) transgenics kb, a central nervous system-specific enhancer at -0.5/-0.1 kb, a hypaxial myotome enhancer at 0.5/3.5 kb, an epaxial myotome enhancer at -5.6/-4.6 kb, and branchial enhancers at -1.5/-0.5 and 0.5/3.5 kb [6, 7, 27] . Gene regulation of Myf5 in frog is apparently quite different, because only a relatively short region of flanking DNA (about 1.2 kb) is sufficient to drive endogenous Xenopus Xmyf5 expression at gastrula stages. Two negative regulatory elements (an interferon-like regulatory factor and a distal TCF-3 binding site) have been identified in the Xmyf5 promoter [10, 11] . It seems likely that each species (i.e., mice, zebrafish and Xenopus) uses distinct mechanisms, given the developmental differences in timing and signaling.
The genomic organizations of myf5 regulatory modules are also conserved between mice and zebrafish. As in mouse, the zebrafish regulatory modules that are respon-sible for lineage-specific expression of myf5 are distributed throughout a large (80-kb) region of the mrf4/myf5 locus (Fig. 9) . The locations and functions of some enhancers are similar to those of mouse myf5. For example, the fin muscle enhancer and the cranial muscle enhancer at -80/ -10 kb probably correspond to the mouse limb and head muscle enhancers at -88/-23 kb, a repressive one at -10/-6 kb is similar to the mouse repressor at -58/-8.8 kb, and a spinal cord enhancer at -6/-3 kb is similar to the mouse central nervous system-specific enhancer at -0.5/-0.1 kb ( Fig. 9 ).
On the other hand, however, we also identified enhancers that have not been described in mouse, including a bone enhancer at -6/-3 kb, a notochord enhancer at -3/-2.4 kb, and a presomitic mesoderm enhancer at -290/-1 bp (Fig.  9 ). Epaxial-and hypaxial-specific enhancers have been identified in mouse myf5 [6, 7, 27 ], but we have not seen A proximal element regulates myf5 expression in the presomitic mesoderm muscle lineage-specific enhancers, especially slow and fast muscle enhancers in zebrafish, with the exception of limb and head muscle enhancers. This finding suggests that more transgenic lines that carry shorter elements should be generated, especially deletions within the -80/-10 kb and -10/-6 kb regions. Taken together, we propose that the regulation of zebrafish myf5 is more similar to mouse myf5 than that of Xenopus.
Excellent experimental materials to study transcriptional regulation on myf5
Myf5 is the first member of the MRF family expressed during somitogenesis in zebrafish. Knockdown of myf5 in zebrafish results in malformation of somites and brain defects, indicating that trunk and head myogenesis is impaired, underscoring the importance of understanding the regulation of myf5. Numerous factors have been implicated as upstream regulators of myf5, including extracellular signals, such as shh, wingless (wnt), and fibroblast growth factor (FGF) [28, 29] . Shh, produced by the notochord and floor plate of the neural tube, and Wnt proteins, produced by the dorsal neural tube and surface ectoderm, have been implicated in the maintenance of mouse myf5 [8, 21, 30, 31] , Xenopus Xmyf5 [32] , and zebrafish myf5 [33] expression. Together with our previous identification of the cognate trans-acting factor, Foxd3 [15] , these results demonstrate that the complex spatial and temporal pattern of myf5 gene expression is regulated by multiple upstream regulatory modules.
Conclusion
We generated several transgenic lines of zebrafish that contain various lengths of zebrafish myf5 upstream genomic sequence linked to the GFP reporter gene. We demonstrate that the 156-kb genomic sequence (an upstream 80-kb and a downstream 70-kb segment) is able to recapitulate the pattern of endogenous myf5 expression. By dissecting this upstream region, we further show that tissue-specific regulatory elements are organized as modules in various regions of the 5'-flanking sequence. These transgenic lines not only provide excellent materials for studying the regulatory mechanism of myf5, but they also will facilitate mutant screens to identify novel genes that regulate somitogenesis and more detailed studies to the morphogenesis of somites, presomitic mesoderm, and cranial muscles.
Methods
Animals
Embryos were produced using standard procedures [34] and were staged according to standard criteria [35] or by hpf at 28°C. The wild-type line used in this study was AB. Line and gene names follow the zebrafish nomenclature conventions [36] .
BAC library screening
The zebrafish BAC library was obtained from the RZPD [37] , and the screening protocols followed the manufacturer's instructions, with minor modifications. The primary BAC library pools were screened by PCR using the zebrafish myf5 intron 1-specific primers 1261F (5'-TGT-TCATTCACTCATTTTCTTTTCA-3') and 2582R (5'-GCAGTCTTCCTACAATGACAA-3'). The positive clones isolated from the primary pools were further confirmed by screening the secondary pools to isolate a myf5-containing BAC clone.
Pulsed-field gel electrophoresis
DNA from a myf5-containing BAC clone was extracted; digested with EcoRI, HindIII, and SacI; and analyzed by 0.8% Agarose pulsed-field gel electrophoresis (PFGE; Biometra). The electrophoresis conditions were 200 volts
The myf5 upstream region contains modules that repress expression in notochord at 10°C for 24 h with electrode angles at 120°, and rotor speed of 2-6 s. After electrophoresis, the BAC DNA size was analyzed with Kodak 1D image software.
Bioinformatics
We used the zebrafish myf5-specific primers 1261F and 2582R for mapping myf5 against the LN54 radiation hybrid (RH) panel. The RH panel was scored according to Hudson et al. [38] using the public web site [39] . For screening the myf5-containing BAC clone, the junctions of BAC DNA were sequenced using T7 and SP6 primers. These junction sequences and adjacent coding regions were analyzed by BlastN [40] , and the location of the myf5-containing BAC clone was characterized and named myf5(80K).
Generation of a myf5(80K) clone containing the GFP reporter
Plasmid p(myf5(80K):GFP) contains the approximately 80-kb region around myf5 fused to GFP (Fig. 1A) . Basically, we followed the protocols described by Lee et al. [17] , with some modifications. The cassette used for targeting the myf5 locus was amplified from template pZMYP-82E [4] with primers ZMFP-82F (5'-CTCT-
The myf5 upstream region contains modules that regulate expression in spinal cord, bones, eyes and olfactory-pits For myf5(80K) transformation, 1 µg of myf5(80K) DNA was used to transform competent cells, E. coli DY380. For myf5(80K) modification with GFP, putative transformants harboring myf5(80K) were isolated and grown in LB medium containing 25 µg/ml of chloramphenicol (CAM) overnight at 32°C with shaking at 150 rpm. Subsequently a 0.1% inoculum was cultured in 50 ml of LB-CAM to an OD 600 of 0.8. Then, the bacteria were cultured at 42°C for 15 min, transferred to an ice slurry for 30 min, washed 5 times in ice-cold water, and electroporated immediately. Approximately 2 µg of targeting cassette DNA was mixed with the freshly prepared electrocompetent cells of DY380 carrying myf5(80K). Electroporation was performed at 1.8 kV, 200 Ohms, 25 µF for 3 × 30 s intervals (Gene Pulser Xcell, BioRad). After electroporation, cells were dispersed on the LB plates with 30 µg/ml of kanamycin and incubated at 32°C overnight. Then, recombinants were picked and checked by PCR using primers ZMFP-117F (5'-TTT-GGGTGGGGATCTAGATGGTG-3') and GFP-407R (5'-GTTGCCGTCCT-CCTTGAAGT-3'), and Kan-F (5'-ATGATTGAACAAGATGGATTGC-3') and ZMF-1000R (5'-AGCGAGTTAAGTTTAAAGTCTGACCC-3') to check both integration ends.
Plasmid constructs for promoter analysis (A) pZMYP-9977E
Following our previously described procedure [4] , a 3.7kb SacI-cut fragment from a myf5-positive recombinant bacteriophage was ligated with the SacI-digested plasmid, pZMYP-6212E, in which a -6212/-1 segment of zebrafish myf5 was fused with enhanced GFP (EGFP) cDNA. The resulting plasmid, pZMYP-9977E, contained the -9977/-1 segment of zebrafish myf5 fused with EGFP cDNA (Fig.  1B) .
(B) pZMYP-9977E-ITR
A SalI/EcoRV fragment from pZMYP-6212E [4] was ligated with a Klenow-filled pGEMT-easy vector (Promega), in which the EcoRV site but not the SalI site was retained, to produce an intermediate plasmid, p(6212/1984). Then, a 3.8-kb SacI fragment from a myf5-positive phage clone [4] was ligated with SacI-treated p(6212/1984) to produce another intermediate plasmid, p(9977/1984). Finally, a SacI/EcoRV fragment cut from p(9977/1984) was ligated with SacI/EcoRV-treated pZMYP-6212E-ITR (Fig. 1B) . The resulting plasmid, pZMYP-9977E-ITR, contained the -9977/-1 segment of myf5 and was flanked with inverted terminal repeats of adeno-associated virus (AAV-ITR) ( Fig.  1B) .
(C) pZMYP-6212E-ITR and pZMYP-2937E-ITR
A SalI/AgeI fragment from either pZMYP-6212E or -2937E [4] was ligated with a 4.2-kb SalI/AgeI fragment obtained from pCMV-EGFP-ITR [41] . The resulting plasmids, pZMYP-6212E-ITR and pZMYP-2937E-ITR, contained the Multiple upstream modules regulate zebrafish myf5 expression 
